Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study

BACKGROUND: Somatostatin analogues (SSAs) are indicated to relieve carcinoid syndrome but seem to have antiproliferative effects on neuroendocrine tumours (NETs). This is the first prospective study investigating tumour stabilisation with the long-acting SSA lanreotide Autogel in patients with progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Richard, Marta, Massutí, Bartomeu, Pineda, Eva, Alonso, Vicente, Marmol, Maribel, Castellano, Daniel, Fonseca, Emilio, Galán, Antonio, Llanos, Marta, Sala, Maria Angeles, Pericay, Carlos, Rivera, Fernando, Sastre, Javier, Segura, Ángel, Quindós, Maria, Maisonobe, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853091/
https://www.ncbi.nlm.nih.gov/pubmed/24053191
http://dx.doi.org/10.1186/1471-2407-13-427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853091/
https://www.ncbi.nlm.nih.gov/pubmed/24053191
http://dx.doi.org/10.1186/1471-2407-13-427

Ejemplares similares